Innovative IV Catheter Receives FDA Clearance and Secures Funding from Washington Area Venture Capital Firm (Business Wire)
Yahoo Biz • Dec 1, 2008ROCKVILLE, Md.----The Zitelman Group announced today it has led a $600,000 Series B Preferred equity round for Israel-based medical device firm, Flexicath, Ltd. Flexicath received a 510 clearance from FDA in October, allowing it to place its FirmGripTM sterile catheter… Full Story »
-
Topics:
- B Round

